Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Tyce J. Kearl MD, PhD

Tyce J. Kearl MD, PhD profile photo picture


Institution: Medical College of Wisconsin
Department: Medicine
Division: Hematology and Oncology - Medicine
Program: Bone Marrow Transplant

Member of the Cancer Center

Research Experience

  • Immunotherapy
  • Clinical Expertise

  • Oncologists
  • Methodologies and Techniques

  • Cell Culture Techniques
  • Immune System
  • Sequence Analysis, RNA
  • Single-Cell Analysis
  • Leadership Positions

  • Assistant Director, BMT and Cell Therapy Laboratory
  • Co-Director, Cell Therapy and Immune Monitoring shared resource laboratory
  • MCW Program / Core Facilities

  • Pediatric Oncology
  • Publications (3)

  • Controlling Cytokine Release Syndrome to Harness the Full Potential of CAR-Based Cellular Therapy. (Thakar MS, Kearl TJ, Malarkannan S) Front Oncol 2019;9:1529 PMID: 32076597 PMCID: PMC7006459 02/23/2020    
  • Programmed death receptor-1/programmed death receptor ligand-1 blockade after transient lymphodepletion to treat myeloma. (Kearl TJ, Jing W, Gershan JA, Johnson BD) J Immunol 2013 Jun 01;190(11):5620-8 PMID: 23616570 PMCID: PMC3891840 SCOPUS ID: 2-s2.0-84878099006 04/26/2013       71 Citations
  • Phosphatidylethanolamine is externalized at the surface of microparticles. (Larson MC, Woodliff JE, Hillery CA, Kearl TJ, Zhao M) Biochim Biophys Acta 2012 Dec;1821(12):1501-7 PMID: 22960380 PMCID: PMC3809829 09/11/2012       42 Citations
  • Last update: 03/31/2021